Related Experiment Videos
New therapeutic approaches for cystic fibrosis lung disease
1Royal Brompton Hospital, Sydney Street, London SW3 6NT, UK. j.c.davies@ic.ac.uk
Journal of the Royal Society of Medicine
|September 10, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
F/HN-pseudotyped lentiviral vector efficiently transduces non-human primate airways with no evidence of relevant toxicity.
Molecular therapy. Advances·2026
Diet composition and quality in children with cystic fibrosis in the modulator era: A scoping review.
Clinical nutrition (Edinburgh, Scotland)·2026
Perspective of the European Cystic Fibrosis Society on Improving Global Cystic Fibrosis Care.
Pediatric pulmonology·2026
Function and Structure Relationships With Inflammation Differ in Two Chronic Suppurative Lung Diseases.
Pediatric pulmonology·2026
Seven lessons for financial incentivisation schemes in healthcare: a qualitative study of NHS Resolution's Maternity Incentive Scheme.
Journal of the Royal Society of Medicine·2026
The historical development of sample size estimation: from Huygens and Bernoulli to the present.
Journal of the Royal Society of Medicine·2026
Alfred the Great: a diagnosis.
Journal of the Royal Society of Medicine·2026
Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID services.
Journal of the Royal Society of Medicine·2026
Competition and equity in NHS specialty training, 2021-2024: longitudinal cohort analysis of protected-characteristic outcomes.
Journal of the Royal Society of Medicine·2026
Industrial action and emergency department attendances in England, 2022-2024: a retrospective multicentre causal mediation analysis.
Journal of the Royal Society of Medicine·2026
Programmed cell death in degenerative skeletal diseases: molecular crosstalk and combinatorial therapeutic strategies.
Frontiers in cell and developmental biology·2026
Modeling Risk Group 4 virus infection and antiviral treatment in microfluidic lung organ-on-chips in maximum containment laboratories.
bioRxiv : the preprint server for biology·2026
Orforglipron: An Oral GLP-1 Receptor Agonist for Obesity Treatment.
The Annals of pharmacotherapy·2026
Efficacy and Safety of Tofacitinib Versus Placebo in Patients With Early-Grade Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial.
International journal of rheumatic diseases·2026